While market sentiment has abruptly reversed regarding the AI opportunity for software vendors, we are convinced of the potential of agentic AI in the medium term for the sector, particularly for SAP, which we believe is the best positioned and which we upgrade to Outperform. Nemetschek, Planisware and Sage also seem to offer a good risk/reward trade-off following their recent de-rating. Conversely, we are downgrading Amadeus to Neutral after the reduction in its discount vs peers.
Alors que le sentiment du marché s’est brutalement retourné concernant l’opportunité de l’IA pour les éditeurs de logiciels, nous sommes convaincus du potentiel lié à l’IA agentique à moyen terme pour le secteur, notamment pour SAP qui nous semble le mieux positionné et que nous upgradons à Surperformance (vs Neutre). Nemetschek, Planisware et Sage nous semblent également offrir un bon risk/reward suite à leur récent de-rating. A l’inverse, nous dégradons Amadeus à Neutre suite à la nette réduct...
Medidata Secures a Leader Position in Everest Group’s PEAK Matrix® Assessment for eCOA, Driving the New Patient Experience Forward Medidata eCOA was the highest Leader recognized in the evaluation, supporting over 1M+ patients and reducing study build timeline by up to 50% compared to the industry standard NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix®...
Medidata Accelerates Business Transformation with Lisa Moneymaker as Chief Strategy Officer Lisa Moneymaker will lead the Strategy organization, reinforcing Medidata's commitment to long-term growth in a rapidly evolving market NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a significant investment in its business transformation, positioning as the organization's new chief strategy officer. Lisa will now lead the company's Strategy team to advance product innovation,...
Unified Data Experience from Medidata Paves Way for New Industry Standard Across Leading Biopharma Companies and Contract Research Organizations Clinical Data Studio has supported 465 global studies since its launch in 2024, reducing data review cycles by up to 80% and accelerating patient profile reviews by 50% NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that , its AI-powered data management solution and an integral part of the , has seen a rise in adoption with m...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.